Seattle Times -- Today’s cancer-fighting tool kit consists mainly of the same trio of options as 50 years ago: Slash, burn and poison. A Seattle biotech company appears poised to add a fourth. A decision is due this week on Dendreon’s application to bring the country’s first cancer-treatment vaccine to market.
